Table 2. Comparative analysis of tumor site and NET grade (n=87).

*Chi-square test was applied; **p-value significant as < 0.05

NET: neuroendocrine tumor; MINEN: mixed neuroendocrine-non-neuroendocrine neoplasm

Tumor Site	NET Grade 1 (n=54)	NET Grade 2 (n=21)	NET Grade3 (n=9)	MINEN (n=3)	Total n=87	P-value*
Appendix	18(33.3%)	1 (4.76%)	0 (0.00%)	0 (0.00%)	19 (21.8%)	0.0001**
Ileum	11 (20.3%)	4 (19.0%)	1 (11.1%)	0 (0.00%)	16 (18.4%)
Rectum	7 (12.9%)	3 (14.2%)	1 (11.1%)	0 (0.00%)	11 (12.6%)
Pancreas	6 (11.1%)	7 (33.3%)	1 (11.1%)	0 (0.00%)	14 (16.1)
Stomach	3 (5.55%)	2 (9.52%)	3 (33.3%)	0 (0.00%)	8 (9.2%)
Colon	4 (7.40%)	2 (9.52%)	2 (22.2%)	0 (0.00%)	8 (9.2%)
Duodenum	4 (7.40%)	1 (4.76%)	0 (0.00%)	0 (0.00%)	5 (5.7%)
Gall Bladder	0 (0.00%)	0 (0.00%)	1 (11.1%)	3 (100%)	4 (4.6%)
Esophagus	1 (1.85%)	1 (4.76%)	0 (0.00%)	0 (0.00%)	2 (2.3%)